The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer’s Disease Brain: A Review
Open accessAbstract
This review proposes that LPS (Lipopolysaccharide, found in the wall of all Gram-negative bacteria) could play a role in causing sporadic Alzheimer’s Disease (AD). This is based in part upon recent studies showing that: Gram-negative E coli bacteria can form extracellular amyloid; bacterial-encoded 16S rRNA is present in all human brains with over 70% being Gram-negative bacteria; ultrastructural analyses have shown microbes in erythrocytes of AD patients; blood LPS levels in AD patients are 3-fold the levels in control; LPS combined with focal cerebral ischemia and hypoxia produced amyloid-like plaques and myelin injury in adult rat cortex. Moreover, Gram-negative bacterial LPS was found in aging control and AD brains, though LPS levels were much higher in AD brains. In addition, LPS co-localized with amyloid plaques, peri-vascular amyloid, neurons, and oligodendrocytes in AD brains. Based upon the postulate LPS caused oligodendrocyte injury, degraded Myelin Basic Protein (dMBP) levels were found to be much higher in AD compared to control brains. Immunofluorescence showed that the dMBP co-localized with β amyloid (Aβ) and LPS in amyloid plaques in AD brain, and dMBP and other myelin molecules were found in the walls of vesicles in periventricular white matter. These data led to the hypothesis that LPS acts on leukocyte and microglial TLR4-CD14/TLR2 receptors to produce NFĸB mediated increases of cytokines which increase Aβ levels, damage oligodendrocytes and produce myelin injury found in AD brain. Since Aβ1-42 is also an agonist for TLR4 receptors, this could produce a vicious cycle that accounts for the relentless progression of AD. Thus, LPS, the TLR4 receptor complex, and Gram-negative bacteria might be treatment or prevention targets for sporadic AD. Keywords: Alzheimer’s disease, Lipopolysaccharide, Cytokines, TLR4, CD14, Myelin, MBP, oligodendrocytes, Amyloid plaque, perivascular amyloid
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758
The central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513
Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.019 · Cited by 1,382
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
Selmaj, K. W., & Raine, C. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230405 · Cited by 1,368
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 2×
“, 2010), meta-analyses show regular NSAID use is associated with a 2 fold reduction in the odds of developing AD (McGeer et al., 1996).”
BackgroundAlzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900
Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
Zenaro, E., Pietronigro, E., Bianca, V. D., Piacentino, G., Marongiu, L., Budui, S., Turano, E., Rossi, B., Angiari, S., Dusi, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3913 · Cited by 865 · cited 1×
“Since Aβ also acts on TLR4 receptors on both monocytes and neutrophils, this could help explain how neutrophils promote AD-like pathology with cognitive decline via the leukocyte LFA-1 adhesion molecule in two AD mouse models (Zenaro et al., 2015).”
BackgroundThe Genetics of Alzheimer Disease: Back to the Future
Bertram, L., Lill, C. M., & Tanzi, R. E. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.013 · Cited by 834
Neurovascular mechanisms of Alzheimer's neurodegeneration
Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770
The case for rejecting the amyloid cascade hypothesis
Herrup, K. (2015) · Nature Neuroscience · doi:10.1038/nn.4017 · Cited by 768
The Genetics of Alzheimer's Disease
Bertram, L., & Tanzi, R. E. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 760
Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study
Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733
Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study
Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710
Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697
Lehnardt, S., Lachance, C., Patrizi, S., Lefebvre, S., Follett, P. L., Jensen, F. E., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02478.2002 · Cited by 689
Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672 · cited 1×
“In addition, BBB breakdown has been demonstrated in humans with mild cognitive impairment (MCI) and early AD before brain atrophy and dementia (Montagne et al., 2017).”
BackgroundMinter, M. R., Zhang, C., Leone, V., Ringus, D. L., Zhang, X., Oyler-Castrillo, P., Musch, M. W., Liao, F., Ward, J. F., Holtzman, D. M., et al. (2016) · Scientific Reports · doi:10.1038/srep30028 · Cited by 655
Banks, W. A., Gray, A. M., Erickson, M. A., Salameh, T. S., Damodarasamy, M., Sheibani, N., Meabon, J. S., Wing, E. E., Morofuji, Y., Cook, D. G., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0434-1 · Cited by 636
LPS-induced Cytokine Production in Human Monocytes and Macrophages
Rossol, M., Heine, H., Meusch, U., Quandt, D., Klein, C., Sweet, M. J., & Hauschildt, S. (2011) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v31.i5.20 · Cited by 622
Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H. (2016) · Radiology · doi:10.1148/radiol.2016152244 · Cited by 601
Poole, S., Singhrao, S. K., Kesavalu, L., Curtis, M. A., & Crean, S. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-121918 · Cited by 598
Predictors of cognitive decline and mortality of aged people over a 10‐year period
Tilvis, R. S., Kahonen-Vare, M. H., Jolkkonen, J., Valvanne, J., Pitkala, K. H., & Strandberg, T. E. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m268 · Cited by 578
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546 · cited 1×
“Myelin Injury in AD Brain Myelin injury has been recognized in AD brain for some time, including the very first report of AD pathology by Alzheimer (Alzheimer et al., 1991; Scheltens et al., 1995; Englund, 1998; Möller and Graeber, 1998; Bartzokis, 2011).”
BackgroundRole of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease
Walter, S., Letiembre, M., Liu, Y., Heine, H., Penke, B., Hao, W., Bode, B., Manietta, N., Walter, J., Schulz-Schüffer, W., et al. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110455 · Cited by 543
Lee, S., Viqar, F., Zimmerman, M. E., Narkhede, A., Tosto, G., Benzinger, T. L. S., Marcus, D. S., Fagan, A. M., Goate, A., Fox, N. C., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24647 · Cited by 542
Protective effects of NSAIDs on the development of Alzheimer disease
Vlad, S. C., Miller, D. R., Kowall, N. W., & Felson, D. T. (2008) · Neurology · doi:10.1212/01.wnl.0000311269.57716.63 · Cited by 535
The blood-brain barrier and immune function and dysfunction
Banks, W. A., & Erickson, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.031 · Cited by 523 · cited 1×
“Since LPS does not enter normal brain when given alone (Banks and Erickson, 2010; Banks et al., 2015), it is likely that other factors contribute to LPS entry into aging brain including ischemia, hypoxia, peripheral cytokines and other factors.”
BackgroundGram-negative bacterial molecules associate with Alzheimer disease pathology
Zhan, X., Stamova, B., Jin, L.-W., DeCarli, C., Phinney, B., & Sharp, F. R. (2016) · Neurology · doi:10.1212/wnl.0000000000003391 · Cited by 521
Self-citationEndogenous ligands of TLR2 and TLR4: agonists or assistants?
Erridge, C. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1209775 · Cited by 518
Models of white matter injury: Comparison of infectious, hypoxic‐ischemic, and excitotoxic insults
Hagberg, H., Peebles, D., & Mallard, C. (2002) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10007 · Cited by 449
Inflammatory markers and the risk of Alzheimer disease: The Framingham Study
Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Wolf, P. A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000263217.36439.da · Cited by 440 · cited 1×
“Another study showed cognitively intact older individuals in the top tertile for leukocyte IL1β or TNFα production have∼3 times increased risk of developing AD compared to those in the lowest tertile (Tan et al., 2007).”
BackgroundSheline, Y. I., Morris, J. C., Snyder, A. Z., Price, J. L., Yan, Z., D'Angelo, G., Liu, C., Dixit, S., Benzinger, T., Fagan, A., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3987-10.2010 · Cited by 437
Grammas, P. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-26 · Cited by 432 · cited 3×
“Thus, NSAIDS may delay the onset of AD, but once it develops NSAIDS do not appear to affect the course of AD, suggesting an opportunity for intervention prior to disease onset (Grammas, 2011; Butchart and Holmes, 2012).”
BackgroundZlokovic, B. V., Martel, C. L., Matsubara, E., McComb, J. G., Zheng, G., McCluskey, R. T., Frangione, B., & Ghiso, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4229 · Cited by 430
SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., & Carlson, G. A. (1999) · Nature Neuroscience · doi:10.1038/5715 · Cited by 399
Kuo, H.-K., Yen, C.-J., Chang, C.-H., Kuo, C.-K., Chen, J.-H., & Sorond, F. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70099-5 · Cited by 399
Sheng, J. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00069-x · Cited by 388
The dormant blood microbiome in chronic, inflammatory diseases
Potgieter, M., Bester, J., Kell, D. B., & Pretorius, E. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv013 · Cited by 383
Zhao, Y., Jaber, V., & Lukiw, W. J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00318 · Cited by 379
Tooth loss, dementia and neuropathology in the Nun Study
Stein, P. S., Desrosiers, M., Donegan, S. J., Yepes, J. F., & Kryscio, R. J. (2007) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2007.0046 · Cited by 375
Selkoe, D. J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004457 · Cited by 363
Riviere, G. R., Riviere, K. H., & Smith, K. S. (2002) · Oral Microbiology and Immunology · doi:10.1046/j.0902-0055.2001.00100.x · Cited by 362
Chen, C.-K., Wu, Y.-T., & Chang, Y.-C. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0282-6 · Cited by 359
Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model
UJIIE, M., DICKSTEIN, D. L., CARLOW, D. A., & JEFFERIES, W. A. (2003) · Microcirculation · doi:10.1038/sj.mn.7800212 · Cited by 351
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide
Liu, Y., Walter, S., Stagi, M., Cherny, D., Letiembre, M., Schulz-Schaeffer, W., Heine, H., Penke, B., Neumann, H., & Fassbender, K. (2005) · Brain · doi:10.1093/brain/awh531 · Cited by 349
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging
Scheltens, P., Barkhof, F., Leys, D., Wolters, E. C., Ravid, R., & Kamphorst, W. (1995) · Neurology · doi:10.1212/wnl.45.5.883 · Cited by 344 · cited 8×
“(A) Western blots for E. coli K99 pili protein showed K99 protein in 3/3 Alzheimer’s disease (AD) White Matter (WM) samples, 2/3 AD Gray Matter (GM) samples and 0/3 Control GM samples. β-actin was used as loading control.”
BackgroundInfluentialDiversity, biogenesis and function of microbial amyloids
Blanco, L. P., Evans, M. L., Smith, D. R., Badtke, M. P., & Chapman, M. R. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2011.11.005 · Cited by 320
Zhang, R., Miller, R. G., Gascon, R., Champion, S., Katz, J., Lancero, M., Narvaez, A., Honrada, R., Ruvalcaba, D., & McGrath, M. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.017 · Cited by 319
Mouse models of Alzheimer's disease
Hall, A. M., & Roberson, E. D. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.017 · Cited by 317
16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer’s Post-Mortem Brain
Emery, D. C., Shoemark, D. K., Batstone, T. E., Waterfall, C. M., Coghill, J. A., Cerajewska, T. L., Davies, M., West, N. X., & Allen, S. J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00195 · Cited by 317
The LPS receptor (CD14) links innate immunity with Alzheimer's disease
Fassbender, K., Walter, S., Kühl, S., Landmann, R., Ishii, K., Bertsch, T., Stalder, A. K., Muehlhauser, F., Liu, Y., Ulmer, A. J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0364fje · Cited by 307
LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
Lee, D. C., Rizer, J., Selenica, M.-L. B., Reid, P., Kraft, C., Johnson, A., Blair, L., Gordon, M. N., Dickey, C. A., & Morgan, D. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-56 · Cited by 293
Shen, L., Liu, L., & Ji, H.-F. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160884 · Cited by 277
Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada
Tyas, S. L., Manfreda, J., Strain, L. A., & Montgomery, P. R. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.3.590 · Cited by 272
Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease
Villegas-Llerena, C., Phillips, A., Garcia-Reitboeck, P., Hardy, J., & Pocock, J. M. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.10.004 · Cited by 270
Periodontal disease associates with higher brain amyloid load in normal elderly
Kamer, A. R., Pirraglia, E., Tsui, W., Rusinek, H., Vallabhajosula, S., Mosconi, L., Yi, L., McHugh, P., Craig, R. G., Svetcov, S., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.038 · Cited by 268
Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide
Verma, S., Nakaoke, R., Dohgu, S., & Banks, W. A. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.10.005 · Cited by 265
Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease
Meyer, E. P., Ulmann-Schuler, A., Staufenbiel, M., & Krucker, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709788105 · Cited by 260 · cited 1×
“Using vascular corrosion casts, the 3D arrangement of the brain vessels is abnormal in a mouse model of AD prior to appearance of amyloid plaques (Meyer et al., 2008).”
BackgroundPang, Y., Cai, Z., & Rhodes, P. G. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00606-5 · Cited by 248
Wu, Z., Ni, J., Liu, Y., Teeling, J. L., Takayama, F., Collcutt, A., Ibbett, P., & Nakanishi, H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.06.002 · Cited by 238
Desai, M. K., Mastrangelo, M. A., Ryan, D. A., Sudol, K. L., Narrow, W. C., & Bowers, W. J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100087 · Cited by 232 · cited 1×
“Clinically, WMH are more highly associated with preclinical AD than imaging and cognitive markers of neurodegeneration; and WMH are now considered a core feature of dominantly inherited AD (Desai et al., 2010; Kandel et al., 2016; Lee et al., 2016).”
BackgroundThe case described by Alois Alzheimer in 1911
Möller, H.-J., & Graeber, M. B. (1998) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050027 · Cited by 224
Ishida, N., Ishihara, Y., Ishida, K., Tada, H., Funaki-Kato, Y., Hagiwara, M., Ferdous, T., Abdullah, M., Mitani, A., Michikawa, M., et al. (2017) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-017-0015-x · Cited by 222
Neuropathology of white matter changes in Alzheimer’s disease and vascular dementia
Englund, E. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051183 · Cited by 213
Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging
van de Haar, H. J., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Wong, S. M., Hofman, P. A. M., Burgmans, S., Verhey, F. R. J., & Backes, W. H. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.006 · Cited by 207
Serum IgG Antibody Levels to Periodontal Microbiota Are Associated with Incident Alzheimer Disease
Noble, J. M., Scarmeas, N., Celenti, R. S., Elkind, M. S. V., Wright, C. B., Schupf, N., & Papapanou, P. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114959 · Cited by 205
Association between Dementia and Infectious Disease: Evidence from a Case-Control Study
Dunn, N., Mullee, M., Perry, V. H., & Holmes, C. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000165511.52746.1f · Cited by 197
Focal demyelination in Alzheimer’s disease and transgenic mouse models
Mitew, S., Kirkcaldie, M. T. K., Halliday, G. M., Shepherd, C. E., Vickers, J. C., & Dickson, T. C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0657-2 · Cited by 186
Can oral infection be a risk factor for Alzheimer's disease?
Olsen, I., & Singhrao, S. K. (2015) · Journal of Oral Microbiology · doi:10.3402/jom.v7.29143 · Cited by 180
Progress in Periventricular Leukomalacia
Deng, W., Pleasure, J., & Pleasure, D. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1291 · Cited by 178
Vascular oxidative stress in Alzheimer disease
Zhu, X., Smith, M. A., Honda, K., Aliev, G., Moreira, P. I., Nunomura, A., Casadesus, G., Harris, P. L. R., Siedlak, S. L., & Perry, G. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.039 · Cited by 175
Association between periodontitis and alzheimer′s disease
Abbayya, K., Chidambar, Y., Naduwinmani, S., & Puthanakar, N. (2015) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.159325 · Cited by 175
Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD).
Zhao, Y., & Lukiw, W. J. (2015) · PubMed · Cited by 174
Microbial-generated amyloids and Alzheimer's disease (AD)
Hill, J. M., & Lukiw, W. J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00009 · Cited by 173
Zhao, Y., Cong, L., Jaber, V., & Lukiw, W. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01064 · Cited by 169
Pang, Y., Campbell, L., Zheng, B., Fan, L., Cai, Z., & Rhodes, P. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.040 · Cited by 167
Zhou, H., Lapointe, B. M., Clark, S. R., Zbytnuik, L., & Kubes, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8103 · Cited by 166
Miklossy, J., Khalili, K., Gern, L., Ericson, R. L., Darekar, P., Bolle, L., Hurlimann, J., & Paster, B. J. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6608 · Cited by 163
Brickman, A. M., Honig, L. S., Scarmeas, N., Tatarina, O., Sanders, L., Albert, M. S., Brandt, J., Blacker, D., & Stern, Y. (2008) · Archives of Neurology · doi:10.1001/archneur.65.9.1202 · Cited by 160
Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
Hammond, C. J., Hallock, L. R., Howanski, R. J., Appelt, D. M., Little, C. S., & Balin, B. J. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-121 · Cited by 156
White, L., Small, B. J., Petrovitch, H., Ross, G. W., Masaki, K., Abbott, R. D., Hardman, J., Davis, D., Nelson, J., & Markesbery, W. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705281872 · Cited by 155
Twenty years of Alzheimer’s disease‐causing mutations
Goate, A., & Hardy, J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07575.x · Cited by 152
Li, X., Long, J., He, T., Belshaw, R. D., & Scott, J. (2015) · Scientific Reports · doi:10.1038/srep12393 · Cited by 152
Branton, W. G., Ellestad, K. K., Maingat, F., Wheatley, B. M., Rud, E., Warren, R. L., Holt, R. A., Surette, M. G., & Power, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054673 · Cited by 149
Cerebral glucose metabolism in preclinical and prodromal Alzheimer’s disease
Herholz, K. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.136 · Cited by 148
Li, J., Ramenaden, E. R., Peng, J., Koito, H., Volpe, J. J., & Rosenberg, P. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3995-07.2008 · Cited by 147
Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease
Hunt, A., Schönknecht, P., Henze, M., Seidl, U., Haberkorn, U., & Schröder, J. (2007) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2006.12.003 · Cited by 146 · cited 1×
“Cerebral glucose metabolism is decreased in preclinical and prodromal AD before symptoms (Hunt et al., 2007; Herholz, 2010).”
BackgroundErickson, M. A., Hartvigson, P. E., Morofuji, Y., Owen, J. B., Butterfield, D. A., & Banks, W. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-150 · Cited by 145 · cited 1×
“LPS also increases Aβ levels in brain by acting at the blood brain barrier and impairing LRP which is responsible for Aβ efflux from brain (Erickson et al., 2012; Banks et al., 2015).”
BackgroundNFκB-dependent Control of BACE1 Promoter Transactivation by Aβ42
Buggia-Prévot, V., Sévalle, J., Roßner, S., & Checler, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706579200 · Cited by 141
Alzheimerʼs disease—a spirochetosis?
Miklossy, J. (1993) · Neuroreport · doi:10.1097/00001756-199307000-00002 · Cited by 136
Animal models of Alzheimer disease: historical pitfalls and a path forward
Cavanaugh, S. E. (2014) · ALTEX · doi:10.14573/altex.1310071 · Cited by 132
Alzheimer Disease -- A Spirochetosis?
Miklossy, J. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_7 · Cited by 130
Complement receptor 1 (CR1) and Alzheimer's disease
Crehan, H., Holton, P., Wray, S., Pocock, J., Guerreiro, R., & Hardy, J. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.07.017 · Cited by 129
Increased Cerebrospinal Fluid Helicobacter Pylori Antibody in Alzheimer’s Disease
Kountouras, J., Boziki, M. K., Gavalas, E., Zavos, C., Deretzi, G., Grigoriadis, N., Tsolaki, M., Chatzopoulos, D., Katsinelos, P., Tzilves, D., et al. (2009) · International Journal of Neuroscience · doi:10.1080/00207450902782083 · Cited by 129
Past exposure to vaccines and subsequent risk of Alzheimer's disease.
Verreault, R., Laurin, D., Lindsay, J., & Serres, G. D. (2001) · Europe PMC (PubMed Central) · Cited by 125
Meta-Analysis of Nonsteroidal Antiinflammatory Drug Use and Risk of Dementia
de Craen, A. J. M., Gussekloo, P. J., Vrijsen, B., & Westendorp, R. G. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi029 · Cited by 124
Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis
Gaultier, A., Wu, X., Le Moan, N., Takimoto, S., Mukandala, G., Akassoglou, K., Campana, W. M., & Gonias, S. L. (2009) · Journal of Cell Science · doi:10.1242/jcs.040717 · Cited by 118
Rahkonen, T. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.4.519 · Cited by 118
Zhan, X., Jickling, G. C., Ander, B. P., Stamova, B. S., Liu, D., Kao, P. F., Zelin, M. A., Jin, L., DeCarli, C. S., & Sharp, F. R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142013 · Cited by 115
Self-citationReed-Geaghan, E. G., Reed, Q. W., Cramer, P. E., & Landreth, G. E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2637-10.2010 · Cited by 115
Direct Visualization of Fungal Infection in Brains from Patients with Alzheimer's Disease
Pisa, D., Alonso, R., Juarranz, Á., Rábano, A., & Carrasco, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141386 · Cited by 114
An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease
Imbimbo, B. P. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903066780 · Cited by 114
Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis
Branton, W. G., Lu, J., Surette, M. G., Holt, R. A., Lind, J. C., Laman, J. D., & Power, C. (2016) · Scientific Reports · doi:10.1038/srep37344 · Cited by 111
The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke
Winek, K., Dirnagl, U., & Meisel, A. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0475-x · Cited by 108 · cited 1×
“…3 February 2018 | Volume 10 | Article 42 microbiome is implicated in normal neurodevelopment, autism spectrum disorders, schizophrenia, depression, Parkinson’s, multiple sclerosis, stroke and aging (Branton et al., 2016; Sampson et al., 2016; Sharon et al., 2016; Winek et al., 2016).”
BackgroundKandel, B. M., Avants, B., Gee, J. C., McMillan, C. T., Erus, G., Doshi, J. J., Davatzikos, C. A., Wolk, D. A., & Initiative, A. D. N. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.03.001 · Cited by 108
Couttas, T. A., Kain, N., Suchowerska, A. K., Quek, L., Turner, N. A., Fath, T., Garner, B., & Don, A. S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.027 · Cited by 108
On certain peculiar diseases of old age
Alzheimer, A., Förstl, H., & Levy, R. (1991) · History of Psychiatry · doi:10.1177/0957154x9100200505 · Cited by 105
Lövheim, H., Olsson, J., Weidung, B., Johansson, A., Eriksson, S., Hallmans, G., & Elgh, F. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161305 · Cited by 103
Alzheimer's Disease: Cerebrovascular Dysfunction, Oxidative stress, and Advanced Clinical Therapies
Marlatt, M. W., Lucassen, P. J., Perry, G. L., Smith, M. A., & Zhu, X. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15206 · Cited by 97
Amyloid β1–42 oligomer inhibits myelin sheet formation in vitro
Horiuchi, M., Maezawa, I., Itoh, A., Wakayama, K., Jin, L., Itoh, T., & DeCarli, C. S. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.007 · Cited by 96
Paintlia, M. K., Paintlia, A. S., Contreras, M. A., Singh, I., & Singh, A. K. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.011 · Cited by 93
Xie, D., Shen, F., He, S., Chen, M., Han, Q., Fang, M., Zeng, H., Chen, C., & Deng, Y. (2015) · Glia · doi:10.1002/glia.22950 · Cited by 88
Myelin Injury and Degraded Myelin Vesicles in Alzheimer’s Disease
Zhan, X., Jickling, G. C., Ander, B. P., Liu, D., Stamova, B. S., Cox, C. D., Jin, L. W., DeCarli, C. S., & Sharp, F. R. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140131120922 · Cited by 86
Self-citationGuglielmotto, M., Tamagno, E., & Danni, O. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.93 · Cited by 86
van de Haar, H. J., Jansen, J. F. A., Jeukens, C. R. L. P. N., Burgmans, S., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., van Osch, M. J. P., & Backes, W. H. (2017) · Medical Physics · doi:10.1002/mp.12328 · Cited by 85
Deng, Y., Xie, D., Fang, M., Zhu, G., Chen, C., Zeng, H., Lu, J., & Charanjit, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087420 · Cited by 82
Histological and Direct Evidence for the Role of Complement in the Neuroinflammation of AD
Veerhuis, R. (2011) · Current Alzheimer Research · doi:10.2174/156720511794604589 · Cited by 80
Bester, J., Soma, P., Kell, D. B., & Pretorius, E. (2015) · Oncotarget · doi:10.18632/oncotarget.6074 · Cited by 80
Chapter 3 Cerebrovascular and Cardiovascular Pathology in Alzheimer's Disease
de la Torre, J. C. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)00403-6 · Cited by 79
Rahkonen, T., Mâkelà, H., Paanila, S., Halonen, P. M., Slvenius, J., & Sulkava, R. O. (2000) · International Psychogeriatrics · doi:10.1017/s1041610200006591 · Cited by 76
Are NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment
Imbimbo (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00019 · Cited by 75
Scott, A. J., Oyler, B. L., Goodlett, D. R., & Ernst, R. K. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.01.004 · Cited by 75
Association between the Polymorphisms of TLR4 and CD14 Genes and Alzheimers Disease
Balistreri, C. R., Grimaldi, M., Chiappelli, M., Licastro, F., Castiglia, L., Listì, F., Vasto, S., Lio, D., Caruso, C., & Candore, G. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786264089 · Cited by 74
Vollmar, P., Kullmann, J. S., Thilo, B., Claussen, M. C., Rothhammer, V., Jacobi, H., Sellner, J., Nessler, S., Korn, T., & Hemmer, B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001765 · Cited by 73
Guglielmotto, M., Monteleone, D., Boido, M., Piras, A., Giliberto, L., Borghi, R., Vercelli, A., Fornaro, M., Tabaton, M., & Tamagno, E. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00854.x · Cited by 71
Degradation of Amyloid β Protein by Purified Myelin Basic Protein
Liao, M.-C., Ahmed, M., Smith, S. O., & Nostrand, W. E. V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050856 · Cited by 71
Clusterin in Alzheimer's disease
Wu, Z., Yu, J., Li, Y., & Tan, L. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-394317-0.00011-x · Cited by 67
de Haas, C. J. C., van Leeuwen, E. M. M., van Bommel, T., Verhoef, J., van Kessel, K. P. M., & van Strijp, J. A. G. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.1753-1759.2000 · Cited by 65
Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A
Liu, J., Wang, D., Li, S.-Q., Yu, Y., & Ye, R. D. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0493-y · Cited by 58 · cited 3×
“, 2000), it binds MBP (Raziuddin and Morrison, 1981) and LPS promotes tau hyper phosphorylation (Kitazawa et al., 2005; Lee et al., 2010; Liu et al., 2016).”
BackgroundCivitelli, L., Marcocci, M. E., Celestino, I., Piacentini, R., Garaci, E., Grassi, C., Chiara, G. D., & Palamara, A. T. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0344-0 · Cited by 55
Belkacemi, A., & Ramassamy, C. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.020 · Cited by 53
Bai, Z., Stamova, B. S., Xu, H., Ander, B. P., Wang, J., Jickling, G. C., Zhan, X., Liu, D., Han, G., Jin, L., et al. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000022 · Cited by 53
Self-citationReviewGenetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease
Veurink, G., Fuller, S. J., Atwood, C., & Martins, R. N. (2003) · Annals of Human Biology · doi:10.1080/03014460310001620144 · Cited by 49
Zhan, X., Cox, C. D., Ander, B. P., Liu, D., Stamova, B. S., Jin, L., Jickling, G. C., & Sharp, F. R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143072 · Cited by 43
Self-citationJudith Miklossy, A., Kasas, S., Janzer, R. C., Ardizzoni, F., & der Loos, H. V. (1994) · Neuroreport · doi:10.1097/00001756-199406020-00010 · Cited by 43
Enkhbaatar, P., Nelson, C., Salsbury, J. R., Carmical, J. R., Torres, K. E. O., Herndon, D. N., Prough, D. S., Luan, L., & Sherwood, E. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144345 · Cited by 40
Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications
Butchart, J., & Holmes, C. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00245.x · Cited by 39
Sequence Variants of Toll Like Receptor 4 and Late-Onset Alzheimer's Disease
Chen, Y.-C., Yip, P.-K., Huang, Y.-L., Sun, Y., Wen, L.-L., Chu, Y.-M., & Chen, T.-F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050771 · Cited by 38
Papuć, E., Kurys-Denis, E., Krupski, W., Tatara, M. R., & Rejdak, K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150309 · Cited by 38
Zhao, Y. D., Zhao, H., Lobo, N., Guo, X., Gentleman, S., & Ma, D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131799 · Cited by 35
Ou-Yang, M.-H., & Van Nostrand, W. E. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-134 · Cited by 30
N-terminal Domain of Myelin Basic Protein Inhibits Amyloid β-Protein Fibril Assembly
Liao, M.-C., Hoos, M. D., Aucoin, D., Ahmed, M., Davis, J., Smith, S. O., & Nostrand, W. E. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169599 · Cited by 30
Fan, L.-W., Mitchell, H. J., Tien, L.-T., Rhodes, P. G., & Cai, Z. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.003 · Cited by 26
IKEDA, M., Hamada, K., Sumitomo, N., OKAMOTO, H., & Sakakibara, B. (1999) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.63.1006 · Cited by 24
Interaction between CD14 and LXRβ genes modulates Alzheimer's disease risk
Rodríguez‐Rodríguez, E., Sánchez‐Juan, P., Mateo, I., Infante, J., Sánchez‐Quintana, C., García‐Gorostiaga, I., Berciano, J., & Combarros, O. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.08.001 · Cited by 20
The role of the TLR4/NF-κB signaling pathway in Aβ accumulation in primary hippocampal neurons.
Wu, D., Zhang, X., Zhao, M., & Zhou, A. (2015) · PubMed · Cited by 19
Fine Mapping of the Amyloid β-Protein Binding Site on Myelin Basic Protein
Kotarba, A. E., Aucoin, D., Hoos, M. D., Smith, S. O., & Nostrand, W. E. V. (2013) · Biochemistry · doi:10.1021/bi4001936 · Cited by 17
Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.668 · Cited by 10
Cited by
Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration
Batista, C. R. A., Gomes, G. F., Candelario-Jalil, E., Fiebich, B. L., & de Oliveira, A. C. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092293 · Cited by 529
“The role of LPS in the development of AD is reviewed by [32,33].”
BackgroundThe endotoxin hypothesis of neurodegeneration
Brown, G. C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1564-7 · Cited by 457
The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease
Sun, E., Motolani, A., Campos, L., & Lu, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168972 · Cited by 361
Marizzoni, M., Cattaneo, A., Mirabelli, P., Festari, C., Lopizzo, N., Nicolosi, V., Mombelli, E., Mazzelli, M., Luongo, D., Naviglio, D., et al. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200306 · Cited by 333
The role of lipopolysaccharide-induced cell signalling in chronic inflammation
Page, M. J., Kell, D. B., & Pretorius, E. (2022) · Chronic Stress · doi:10.1177/24705470221076390 · Cited by 315
Metadata
- Authors
- Zhan, X., Stamova, B., & Sharp, F. R.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-02-22
- Volume
- 10
- Pages
- 42-42
- ISSN
- 1663-4365 (ISSN-L)
- OpenAlex
- W2789258764
- Cited by
- 351
- References
- 162
- FWCI
- 18.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.